To further confirm the in vivo relevance of our observations, we used NLRP3 deficient (NLRP3-/-) mice or wild-type (WT) mice to evaluate the effect of NLRP3 on IL-33 mediated AD pathological process. Here, IL33 is linked to Alzheimer disease.